Evangelista Sagnelli

researcher

Born 2000-01-01

Evangelista Sagnelli is …
instance of (P31):
humanQ5

External links are
P10949IRIS UNICAMPANIA author ID04444
P496ORCID iD0000-0003-2817-8436
P1153Scopus author ID55410853200
7004951151

P735given nameEvangelistaQ3735207
EvangelistaQ3735207
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q37090659A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.
Q42287432Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.
Q43760925Abnormal steroid sulfate in plasma of women with intrahepatic cholestasis of pregnancy
Q78414181Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer
Q43046943Absence of occult HCV infection in HIV-positive patients.
Q43037083Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases
Q34675557Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy
Q43042294Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases.
Q43510018Acute hepatitis B in children with papular acrodermatitis.
Q42232261Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin
Q38195262Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment
Q45405567Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection
Q67682386Acute viral hepatitis in Italy. Results of a collaborative study
Q38207725Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection
Q47586705An update on the treatment options for HBV/HCV coinfection
Q42234731Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C.
Q42222997Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients
Q36319267Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop
Q50707984Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
Q40595308Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis
Q71707650Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis
Q39541014CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection.
Q42490118Can HCV affect the efficacy of anti-HIV treatment?
Q28539814Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C
Q40113130Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients
Q42999777Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases
Q39494125Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology
Q44769298Characteristics of liver cirrhosis in Italy: results from a multicenter national study
Q43047852Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection
Q72715292Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen
Q42210385Clinical and virological characteristics associated with severe acute hepatitis B.
Q45417133Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection
Q38074390Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection
Q71190327Clinical aspects of delta agent infection in southern Italy
Q47828777Clinical experience with daptomycin in Italy: results from a registry study of the treatment of Gram-positive infections between 2006 and 2009.
Q38779980Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals
Q67760965Clinical presentation and natural history of chronic persistent hepatitis. A multicentre retrospective study on 1197 cases
Q42266477Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
Q26773676Clinical significance of hepatitis B surface antigen mutants
Q70032258Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies
Q90894096Correction to: HBV molecular epidemiology and clinical condition of immigrants living in Italy
Q36845533D-penicillamine in the treatment of active chronic diseases of the liver. Preliminary data
Q43902489Dane particles-associated hepatitis B core antigen in patients with HBsAg-positive chronic hepatitis
Q39419904Decrease in HDV endemicity in Italy.
Q91560021Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy
Q43524889Delta agent infection: an unfavourable event in HBsAg positive chronic hepatitis
Q93636871Detection of two forms of HBeAg (free-and IgG-bound HBeAg) in patients with HBe antigenemia using staphylococcus bearing protein A
Q54523160Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study.
Q45483149Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres
Q30702953Differential diagnosis between benign and malignant biliary tract obstruction: discriminative usefulness of some clinical and laboratory data
Q77297242Does HIV infection favor the sexual transmission of hepatitis C?
Q71039706Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe
Q39544689Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial
Q34514292Efficacy of Pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis
Q31107505Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey
Q92193515Epidemiological and etiological variations in hepatocellular carcinoma
Q44126919Epidemiological evaluations of human immunodeficiency virus, herpes simplex virus type 1 and 2 and cytomegalovirus infections in drug addicts
Q69244912Epidemiology of HDV infection in Southern Italy
Q33801300Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy
Q64971879Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients.
Q92410137Erratum to "Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients"
Q38679799Etiological factors of chronic hepatitis in Italy: a 2014 national survey
Q39494196Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study
Q81643918Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study
Q52295303Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area.
Q42287905Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy.
Q42255783Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection
Q43898328Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis
Q37544514Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.
Q42215454Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection
Q47573260Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy
Q59361085Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics
Q70610131Geographic differences in HBV related, autoimmune, and cryptogenic chronic active hepatitis
Q45125334HAV replication in acute hepatitis with typical and atypical clinical course
Q39355216HBV and HCV chronic hepatitis and cirrhosis.
Q56335074HBV molecular epidemiology and clinical condition of immigrants living in Italy
Q46099371HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV.
Q43040641HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
Q43032349HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease
Q92724455HDV infection in immigrant populations
Q95277079HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy
Q34545899Helicobacter spp. and liver diseases.
Q33735206Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection
Q38722666Hepatitis A virus strains circulating during 1997-2015 in Campania, a Southern Italy region with periodic outbreaks
Q39000397Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.
Q45866904Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology
Q26765801Hepatitis B virus and hepatitis C virus infection in healthcare workers
Q36269649Hepatitis B virus burden in developing countries
Q26771150Hepatitis B virus infection in immigrant populations
Q37633770Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features
Q38952987Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013.
Q90564809Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12
Q26785981Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
Q45758599Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: a multicentre case-control study
Q26782033Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
Q42996903Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course
Q39494133Hepatitis delta infection in Italian patients: towards the end of the story?
Q42985026Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver).
Q41584146Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration
Q58863669High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients
Q59286728Human hepatitis E virus circulation in Bulgaria: Deep Bayesian phylogenetic analysis for viral spread control in the country
Q59353516Human hepatitis E virus circulation in Bulgaria: Deep Bayesian phylogenetic analysis for viral spread control in the country
Q71274450Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver
Q44245592Immunosuppressive therapy of HBsAg-positive chronic active hepatitis in childhood: a multicentric retrospective study on 139 patients.
Q40819897Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
Q35886670Impact of comorbidities on the severity of chronic hepatitis B at presentation
Q45414950Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy
Q42991017Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index
Q71005011In vitro synthesis of IgG and IgM in patients with HBsAg-positive and HBsAg-negative chronic active hepatitis
Q43040173Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy
Q34283736Infection with the delta agent in chronic HBsAg carriers
Q40559662Infectious diarrhoeas
Q69705157Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis
Q42985571Influence of chronic coinfection with hepatitis B and C virus on liver histology.
Q39419887Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study
Q34263370Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression
Q67970214Interaction between HDV and HBV infection in HBsAg-chronic carriers
Q40182428Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation.
Q45749997Intrafamilial transmission of hepatitis delta virus: molecular evidence.
Q44481046Is liver biopsy necessary for hepatitis C virus carriers with persistently normal aminotransferase levels?
Q43035645Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment.
Q39320945Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis
Q59306868Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons
Q59306861Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011
Q42257697Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
Q39004446Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART.
Q26777511Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact
Q44269399Liver histology in 34 "HPsAg long-term healthy carriers
Q43085980Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases
Q34811974Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression
Q42991587Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.
Q33648849Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf
Q38135971Management of infections in cirrhotic patients: report of a consensus conference
Q38175238Management of infections pre- and post-liver transplantation: report of an AISF consensus conference
Q39224652Molecular diversity in irregular or refugee immigrant patients with HBV-genotype-E infection living in the metropolitan area of Naples
Q89530878Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy
Q42209108Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region
Q45819082Morphometric study on the distribution of liver necrosis in experimental murine hepatitis by MHV-3 virus
Q58811116Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report
Q40779997Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B.
Q36292486Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C.
Q37641840Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
Q38807875Occult HBV infection in the oncohematological setting
Q41221366Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B.
Q35146790Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors
Q39409509Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency
Q69588210Pharmacokinetics of ciprofloxacin in impaired liver function
Q44251554Polymerase chain reaction (PCR) for the detection of HIV proviral DNA (pDNA) in subjects at risk of infection
Q45257444Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy
Q68204231Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study
Q70265734Radioimmunoassay for HBcAg
Q70271572Radioimmunoassay for hepatitis B core antigen
Q61054082Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
Q38226627Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT).
Q37838047Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients
Q38870182Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates).
Q50283938Reply: To PMID 24442928.
Q59355074Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure
Q52046648Risk management of HBsAg or anti-HCV positive healthcare workers in hospital.
Q36167378Rituximab-based treatment, HCV replication, and hepatic flares
Q41140604Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment
Q35779058Role of genetic polymorphisms in hepatitis C virus chronic infection
Q42245958Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
Q26823538Role of occult hepatitis B virus infection in chronic hepatitis C
Q50103925Salmonella non-typhoid infection: new epidemiological findings
Q44837822Serum anti-HIV IgA in seropositive patients and in subjects at risk of HIV infection
Q72429104Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis
Q42996972Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells
Q41549262TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism
Q40482870TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
Q67377058The differential diagnosis between intrahepatic cholestatic jaundice and viral hepatitis during pregnancy
Q40911738The epidemiology of hepatitis delta infection in Italy over the last 18 years.
Q45147822The epidemiology of hepatitis delta infection in Italy. Promoting Group
Q72802594The etiology of chronic hepatitis in Italy: a multicenter study
Q40257964The growth-hormone in long-term steroid-treated patients with chronic active hepatitis
Q41443935The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B.
Q40445497The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
Q35224155The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Q93055970The phylogenetic approach for viral infectious disease evolution and epidemiology: An updating review
Q72903106The role of H2 antagonists in perennial allergic rhinitis
Q67348486The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases
Q54490638Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection.
Q45355787Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma
Q71052149Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study
Q43605323Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
Q37833228Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop.
Q38352572Treatment of chronic hepatitis C in patients with HIV/HCV coinfection
Q81229927Trends of aetiological factors of hepatocellular carcinoma in Italy
Q47177581VIROLOGICAL PATTERNS OF HCV PATIENTS WITH FAILURE TO INTERFERON-FREE REGIMENS.
Q43000718Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis
Q43040669Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients
Q30795477Virological and clinical aspects of multiple hepatitis virus infections: preliminary data of an italian multicentre study
Q42989673Virological and epitope evolution of HCV infection from acute hepatitis C to subsequent episodes of HCV-related acute liver cell necrosis
Q47556549What is changed in HBV molecular epidemiology in Italy?
Q79805765[Anti-HAV screening patients with chronic hepatitis]
Q62727429[HIV Antigens as complement fixing circulating immune complexes]
Q76333970[Hepatitis viruses and development of hepatocellular carcinoma]
Q71396677[Histochemical studies on the RNA content of the liver and pancreas of mice in ethionine poisoning]
Q73664023[Laboratory diagnosis of HIV infection]
Q70885081[Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies]
Q45929117[Spontaneous and treatment-induced virological dynamic in the plasma, PBMC and liver tissue in a patient with chronic HBV and HCV coinfection].
Q71910711[The role of IFN in the therapy of chronic delta hepatitis]

Search more.